Stock comparison
AMGEN INC is 29.3x more valuable than Immunovant, Inc. by market capitalization ($235.98 B vs $8.06 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 29.3x more valuable than Immunovant, Inc. by market capitalization ($235.98 B vs $8.06 B).
Market value leader
AMGN
AMGEN INC is 29.3x more valuable than Immunovant, Inc. by market capitalization ($235.98 B vs $8.06 B).
Profit leader
AMGN
IMVT: -$505.61M vs AMGN: $7.71B.
| Metric | IMVT | AMGN |
|---|---|---|
| Market cap | $8.06 B | $235.98 B |
| US-listed rank | #1089 | #62 |
| Revenue (latest FY) | - | $36.75B |
| Net income (latest FY) | -$505.61M | $7.71B |
| Net margin | - | 21.0% |
| P/E (trailing FY) | - | 30.6x |
| SEC filings | 611 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 29.3x more valuable than Immunovant, Inc. by market capitalization ($235.98 B vs $8.06 B).
Full pages: Immunovant, Inc. and AMGEN INC, or browse the full rankings.